PubMed · 2002 · 49 citations · 17 references
MedicineMolecular BiologyOncologyDna RepairMolecular OncologyRadiobiologyCellular Radiation ResponseDna DamageDna Damage SignalingRadiation TherapyDna Double-strand BreaksDna RejoiningDna-pk SignalingDna-pkcsDna-pkcs FunctionDouble-strand Dna BreaksIonizing Radiation-induced Dna BreaksNon-small Cell Lung Cancer Treatment
The inhibition of DNA-dependent protein kinase activity with antisense-oligodeoxynucleotide (As-ODN) and its consequences for the rejoining of DNA-double-strand breaks (Dsbs) and radiation sensitivity was studied in human non-small cell lung cancer (NSCLC) cell lines. Cells were transfected with As-ODNs specific for the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs). In comparison, cells were treated with Wortmannin, a potent but nonspecific inhibitor of DNA-PK activity. As-ODN efficiently reduced the kinase activity with an IC50 of about 100-200 IC50 of Wortmannin was at approximately 5-10 micro M. Treatment of cells with 300 nM As-ODN increased the fraction of residual Dsb at 4 h after irradiation by a factor of 4.4, 2.6, and 1.7 in A549, H460, and H661 cells, respectively. The respective values after treatment with 20 micro M Wortmannin were 5.3, 4.3, and 2.2. Inhibition of DNA-PK activity by As-ODN and Wortmannin also decreased the surviving fraction of the NSCLC cell lines. These data show that kinase activity of DNA-PKcs can be specifically inhibited with As-ODN as effective as Wortmannin and results in marked inhibition of DNA-Dsb rejoining and radiosensitization of NSCLC cell lines.
17
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Garth Powis, Rosanne Bonjouklian, Margareta Berggren et al. · PubMed · 1994 · 691 citations
Teresa L. Burgess, Eric F. Fisher, Sandra L. Ross et al. · Proceedings of the National Academy of Sciences · 1995 · 322 citations · Full text
Gilbert Chu · Journal of Biological Chemistry · 1997 · 270 citations · Full text